Form D · Pharmaceuticals
Evogene Ltd.
Rehovot, L3 · CIK 0001574565
Offering snapshot reported Feb 19, 2026 · SEC filing
- Reported sold
- $3.38M Offering amount: $3.38M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 11, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 19, 2026 | Initial | $3,384,616 | No comparison | 1 | SEC filing |
| Sep 4, 2024 | Initial | $0 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $237K
- Finders' fees
- $0
- Form D file number
- 021-574080
Gross proceeds reflect the cash exercise of 3,384,616 existing warrants at an exercise price of $1.00 per share in a warrant inducement transaction. As part of the inducement, the Company issued new warrants to purchase up to 5,076,924 shares. Gross proce
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| A.G.P./Alliance Global Partners | 000008361 |
Source: Form D, filed Feb 19, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Yaron Eldad | Executive |
| Dan Falk | Director |
| Sarit Firon | Director |
| Ofer Haviv | Director, Executive |
| Mark Kapel | Executive |
| Sassi Masliah | Executive |
| Nir Nimrodi | Director |
| Adrian Percy | Director |
| Leon Yehuda Recanati | Director |
| Eyal Ronen | Executive |
| Oded Shoseyov | Director |
| Gabi Tarcic | Executive |
| Ilia Zhidkov | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
13 Gad Feinstein Street Park Rehovot
Rehovot, L3, 7638517
Phone: 97289311900
Rehovot, L3, 7638517
Phone: 97289311900